Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
- Status
- COMPLETED
- Phase
- PHASE3
Pediatric Epilepsy Study
- Status
- COMPLETED
- Phase
- PHASE3
Pediatric Epilepsy Study
- Status
- COMPLETED
- Phase
- PHASE3
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
- Status
- COMPLETED
- Phase
- PHASE4
EPO906 in Carcinoid and Other Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
- Status
- COMPLETED
- Phase
- PHASE3
HORIZON-PFT: Pivotal Fracture Trial
- Status
- COMPLETED
- Phase
- PHASE3
Therapy of Early Chronic Phase CML With Gleevec
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture
- Status
- COMPLETED
- Phase
- PHASE3
PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
- Status
- COMPLETED
- Phase
- NA
Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
- Status
- TERMINATED
- Phase
- PHASE2
Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis
- Status
- COMPLETED
- Phase
- PHASE4
EPO906 Therapy in Patients With Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
EPO906 Therapy in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2